Category: Company News

UPDATE 2-Merck's treatment for urinary, abdominal infections gets FDA approval

(Reuters) – The U.S. Food and Drug Administration has approved Merck & Co Inc’s combination treatment for complicated forms of urinary tract and abdominal infections, the drugmaker said on Wednesday. Recarbrio, approved for patients over 18 years of age, is a combination of a previously approved antibiotic imipenem-cilastatin and Merck’s relebactam. Patients with urinary tract […]

Read More

UPDATE 2-Diabetes devices power Abbott's profit beat, forecast raise

(Reuters) – Abbott Laboratories (ABT.N) beat analysts’ estimates for quarterly profit on Wednesday and raised its full-year adjusted earnings forecast, driven by demand for its FreeStyle Libre blood sugar monitoring device. Sales of FreeStyle Libre, which helps diabetics track their blood sugar levels without having to prick their fingers, surged 63.9% to $433 million in […]

Read More